On the basis of product type, PMR has segmented the glycobiology market into instruments, enzymes, consumables, and reagent kits. Enzymes product type segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of enzymes to conduct various research, this segment is expected to witness high incremental opportunity globally.
Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/glycobiology-market.asp
The global market is expected to reach a value of US$ 1,670.3 Mn by 2024, registering a CAGR of 12.8% between 2016 and 2024, according to a new report by Persistence Market Research (PMR).
On the basis of end user, the glycobiology market has been segmented into biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract research organization, biotechnology industry, academic institutes, and others. PMR estimates that biopharmaceutical companies segment is expected to account for the highest revenue share in end user segment of the global glycobiology market and is expected to witness fastest growth over the forecast period. Factors such as increasing demand for novel drug development, especially for chronic diseases such as cancer and diabetes, is expected to boost revenue share of the biopharmaceutical companies segment. Research laboratories segment is also expected to register a significant growth rate during the forecast period.
By region, the global glycobiology market is segmented into North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). The U.S. is expected to remain dominant market for glycobiology in the North America glycobiology market; whereas APAC region is expected to witness highest growth majorly due to increasing number of research initiatives being conducted in countries such as Japan and China.
Download Report Sample @ http://www.persistencemarketresearch.com/samples/4769
Some key market participants included in the report include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353